---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-093254"
form_type: "8-K"
ticker: "XMTR"
cik: "0001657573"
company_name: "Xometry, Inc."
filed_at: "2024-04-11T23:59:59+00:00"
generated_at: "2026-06-04T00:05:06.713019+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Xometry co-founder and director Laurence Zuriff to step down at 2024 annual meeting due to health

## Summary
- Laurence Zuriff, co-founder and director since May 2013, will not stand for reelection at the 2024 Annual Meeting due to health reasons.
- His Board service and ESG Committee membership will end on the date of the 2024 Annual Meeting.
- Company states the departure is not due to any disagreement with management or company policies.
- Zuriff's decision is voluntary and based on personal health considerations.

## SEC filing metadata
- accession: 0001193125-24-093254
- form_type: 8-K
- ticker: XMTR
- cik: 0001657573
- company_name: Xometry, Inc.
- filed_at: 2024-04-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1657573/000119312524093254/0001193125-24-093254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1657573/000119312524093254/d752880d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-093254
- JSON: https://secwatch.observer/filing/0001193125-24-093254.json
- Plain text: https://secwatch.observer/filing/0001193125-24-093254.txt

## Key facts
- Executive change
  Laurence Zuriff departed as Director at Xometry, Inc..
  - Action: will not stand for reelection
  - Role: Director
  source text: On April 8, 2024, Laurence Zuriff, co-founder and a member of the Board of Directors (“Board”) of Xometry, Inc. (the “Company”) since May 2013, notified the Board that he will not stand for reelection as a director of the Company upon the expiration of his current term, which will expire at the Company’s 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) due to health reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1657573/000119312524093254/0001193125-24-093254-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.